Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
860,970
-
Share change
-
-1,669,824
-
Total reported value
-
$62,903,278
-
Put/Call ratio
-
176%
-
Price per share
-
$73.07
-
Number of holders
-
51
-
Value change
-
-$121,700,461
-
Number of buys
-
22
-
Number of sells
-
14
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2021
As of 30 Jun 2021,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
860,970 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, 20/20 Capital Management, Inc., CITADEL ADVISORS LLC, Orion Portfolio Solutions, LLC, MORGAN STANLEY, OSAIC HOLDINGS, INC., Tower Research Capital LLC (TRC), SUSQUEHANNA INTERNATIONAL GROUP, LLP, and LPL Financial LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.